We performed a quasi-experimental open-label pragmatic study alternating standard of care
(SOC) and oral bedtime melatonin (OBM) at different high doses over 4 consecutive time
periods enrolling all consecutive RT-PCR SARS-CoV-2 severe Covid-19 admissions.